The group is subdivided according to types of parasites.
P01A AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES
This group comprises drugs mainly used for amoeba infections and other protozoal diseases such as giardiasis and trichomoniasis.
All combined preparations containing clioquinol are classified in this group. Formulations of chlorquinaldol and clioquinol for dermatological use are classified in D08AH.
|No DDDs are established in this group.|
Nitroimidazole derivatives used for amoebiasis, trichomoniasis and giardiasis are classified in this group. Formulations for vaginal administration are classified in G01AF. Parenteral formulations mainly used for treatment of anaerobic bacterial infections are classified in J01XD. Fixed combination packages for eradication of Helicobacter pylori are classified in A02BD.
Combinations with antibacterials are classified in J01R.
|The DDDs are based on the treatment of amoebiasis, giardiasis and trichomoniasis. The duration of the treatment periods is not taken into consideration.|
This group comprises luminal amoebicides.
|The DDDs in this group are based on treatment of luminal amoebiasis.|
P01AR Arsenic compounds
This group comprises e.g. glycobiarsol. Combinations containing clioquinol are classified in P01AA.
This group comprises agents, which cannot be classified in the preceding groups. Combinations with clioquinol are classified in P01AA.
Last updated: 2016-12-19